A KDIGO commentary on B Cell and Complement guided therapy in IgAN www.kidney-international.org/article/S008... in Kidney Int Perfectly timed for #NephMadness (and this will be the champion)
NCAA is crazy enough, but I had no idea of this level of nuttery podcasts.apple.com/ca/podcast/e... On Caveville and the UNC-Duke basketball rivalry #NephMadness #MarchMadness

The Economics of Scarcity and ...
The Economics of Scarcity and the UNC-Duke Basketball Game (with Michael Munger)

Podcast Episode · EconTalk · March 16 · 1h 6m

Apple Podcasts
The first #NephMadness commentary lands - and it suggests POCUS in AKI from Dr POCUS himself ajkdblog.org/2026/03/10/n... Which makes me think the Ottawa choice of POCUS in ESRD is right 🤔 though Anna Burgner plays 4D chess 😳

#NephMadness 2026: POCUS – Sto...
#NephMadness 2026: POCUS – Stop Guessing, Start Scanning

Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2026   Abhilash Koratala @NephroP Abhilash Koratala, MD, FASN, FNKF, is a nephrologist–intensivist and Associate Professor…

AJKD Blog

The first #NephMadness commentary lands - and it suggests POCUS in AKI from Dr POCUS himself

https://ajkdblog.org/2026/03/10/nephmadness-2026-pocus-stop-guessing-start-scanning/

Which makes me think the Ottawa choice of POCUS in ESRD is right 🤔 though Anna Burgner plays 4D chess 😳

#NephMadness 2026: POCUS – Stop Guessing, Start Scanning

Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2026   Abhilash Koratala @NephroP Abhilash Koratala, MD, FASN, FNKF, is a nephrologist–intensivist and Associate Professor…

AJKD Blog
B cell therapies in IgAN advance: povetacicept from Vertex www.medscape.com/s/viewarticl... #NephMadness timing was perfect for this Atacicept has competition now (and there’s the Chinese Telitacicept)

Vertex to Seek US Approval Aft...
Vertex to Seek US Approval After Promising Late-stage Results for Kidney Drug

Vertex Pharmaceuticals said on Monday that its experimental drug sharply reduced a key sign of kidney ⁠damage in a late‑stage trial, putting the company on track to seek...

Medscape

B cell therapies in IgAN advance: povetacicept from Vertex

https://www.medscape.com/s/viewarticle/vertex-seek-us-approval-after-promising-late-stage-results-2026a1000787?src=rss

#NephMadness timing was perfect for this

Atacicept has competition now (and there’s the Chinese Telitacicept)

Vertex to Seek US Approval After Promising Late-stage Results for Kidney Drug

Vertex Pharmaceuticals said on Monday that its experimental drug sharply reduced a key sign of kidney ⁠damage in a late‑stage trial, putting the company on track to seek...

Medscape
More pictures from the Ottawa #NephMadness party The fellows really did get quite animated for their second bracket 😂
Closest vote: 🐶 versus 🐈🤷🏽‍♂️ Cleanest/unanimous vote: POCUS Our choices where #BlueRibbonFail is most likely: C3G (Dx over Rx) or Trolls (BKV over CMV) #NephMadness
Swapnil Hiremath #NephJC Sorry just returning from our #NephMadness party - joining in late
The #NephMadness bracketology in Ottawa is on! this year we are going to win.